Woodcock to CDER as Galson named acting surgeon general

Dr. Janet Woodcock will assume the role of acting director of the Center for Drug Evaluation and Research (CDER) as the center's previous director, Dr. Steven Galson, becomes acting surgeon general.

Woodcock will retain her position as deputy commissioner and permanent chief medical officer, and will work with FDA Commissioner Andrew von Eschenbach to launch a national search for a permanent director of the center, the FDA said.

Of Galson, von Eschenbach said: "Because of his accomplishments, Americans have access to safer and more effective medical products than ever before. I know Steven will excel as our nation's chief health educator and Americans will continue to benefit from his dedication to public service."
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.